Recent Major Changes Indications and Usage for Vyvanse VYVANSE is a central nervous system (CNS) stimulant indicated for the treatment of (1): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older Moderate to severe binge eating disorder (BED) in adults Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage (5.5, 8.4) VYVANSE is not indicated for weight loss
FDLI Enforcement and Litigation Conference, Jill Furman, Director Office of Compliance, CDER, December 2025
When semaglutide or tirzepatide activates these receptors, neurotransmitter systems including dopamine, serotonin, and GABA shift in response
No doubt clever marketing and pretty packaging can convince people who are fatigued overweight and living with chronic pain that the answer to their woes lies in subsisting on cabbage soup green smoothies or a diet made up entirely of raw foods
However, it's always wise to consult with a healthcare professional before starting any new supplement regimen, especially if you have pre-existing medical conditions or take medications
Repeat cycles as needed
